Harmony Biosciences to Participate in 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) announced that President and CEO John C. Jacobs will present a company update at the 40th Annual J.P. Morgan Healthcare Conference on January 13, 2022, at 7:30 AM ET. Investor meetings are scheduled from January 10 to January 13, 2022. A webcast of the presentation will be available on the investor page of Harmony's website. Harmony Biosciences focuses on innovative therapies for patients with rare neurological diseases. For more information, visit www.harmonybiosciences.com.

PLYMOUTH MEETING, Pa., Jan. 5, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that Harmony's President and CEO, John C. Jacobs will present a company update and host investor meetings at the upcoming 40th Annual J.P. Morgan Healthcare Conference.

• 40th Annual J.P. Morgan Healthcare Conference
  Presentation: Thursday, January 13, 2022; 7:30AM ET
  1x1 Meetings: Monday, January 10, 2022-Thursday, January 13, 2022

A webcast of the presentation will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.

About Harmony Biosciences 
Harmony Biosciences is a commercial stage pharmaceutical company headquartered in Plymouth Meeting, PA. The Company was established by Paragon Biosciences, LLC, and is focused on providing novel treatment options for people living with rare neurological diseases who have unmet medical needs. For more information on Harmony, please visit the company's website: www.harmonybiosciences.com.

Harmony Biosciences Media Contact: 
Nancy Leone 
215-891-6046 
nleone@harmonybiosciences.com 

Harmony Biosciences Investor Contact:
Patti Bank
ICR Westwicke
415-513-1284
ir@harmonybiosciences.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-40th-annual-jp-morgan-healthcare-conference-301454023.html

SOURCE Harmony Biosciences

FAQ

When is Harmony Biosciences presenting at the J.P. Morgan Healthcare Conference?

Harmony Biosciences will present at the J.P. Morgan Healthcare Conference on January 13, 2022, at 7:30 AM ET.

Who is the CEO of Harmony Biosciences?

The CEO of Harmony Biosciences is John C. Jacobs.

What is the focus of Harmony Biosciences?

Harmony Biosciences focuses on developing therapies for patients with rare neurological diseases.

Where can I watch the Harmony Biosciences presentation?

The presentation can be watched on the investor page of Harmony's website during the conference.

When are the investor meetings for Harmony Biosciences?

Investor meetings for Harmony Biosciences will take place from January 10 to January 13, 2022.